ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 51 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,243,000 | – | 225,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 375,000 | $3,739,000 | 1.40% |
| CVI Holdings, LLC | 223,140 | $2,226,000 | 0.86% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,202,456 | $21,958,000 | 0.59% |
| Ion Asset Management Ltd. | 225,000 | $2,243,000 | 0.57% |
| Altshuler Shaham Ltd | 1,093,859 | $11,343,000 | 0.48% |
| MEITAV INVESTMENT HOUSE LTD | 500,436 | $4,987,000 | 0.33% |
| Clal Insurance Enterprises Holdings Ltd | 595,000 | $5,932,000 | 0.14% |
| New England Private Wealth Advisors LLC | 50,000 | $499,000 | 0.12% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 200,000 | $1,994,000 | 0.08% |
| ING GROEP NV | 30,000 | $299,000 | 0.01% |